Increased risk of tuberculosis transmission in families with microepidemics

R. Vidal, M. Miravitlles, J. A. Cayla, M. Torrella, J. De Gracia, F. Morell

Research output: Contribution to journalArticle

Abstract

In the present study, we analysed: 1) prevalence of TB infection and incidence of disease among family contacts of a cohort of patients with TB; 2) differential characteristics of families with microepidemics and families with ≤1 new case of TB; and 3) efficacy of chemoprophylaxis in this group of contacts. Three thousand and seventy one family contacts of 635 patients with TB were studied. The study consisted of tuberculin skin testing and chest radiography in all cases, and bacteriological studies when active disease was suspected. Contacts were classified as belonging to: families with microepidemics (FME) (those with ≤2 new cases of TB); families with one new case; and families with with no new cases. Chemoprophylaxis was prescribed in contacts following standard recommendations; all were followed up for 12-18 months. Rates of TB infection and disease among families, as well as the incidence of TB disease between those compliant and noncompliant with chemoprophylaxis were compared. Among the 3,071 contacts, 1,264 (41%) were infected and 176 (6%) had TB. Twenty two families with FME (3%) yielded 55 new cases of TB. The prevalence of infection (excluding the TB cases) was 80% in families with FME, 52% in families with one new cases, and 41% in families with no new case (odds ratio (OR) 3.7; 95% confidence interval (95% CI) 2.1- 6.5). Sputum smears were positive in 53% of cases in FME and 24% in non-FME families (OR 3.4; 95% CI 1.7-6.5). Bronchial sample cultures were positive in 84% of patients from FME families but in only 40% of those from non-FME families (OR 7.5; 95% CI 3.6-15.8). Chemoprophylaxis was prescribed in 356 contacts, of whom 296 complied and generated only one new case of TB, whilst there were 13 new cases among the 60 who did not comply (OR 81.6; 95% CI 26.7-248.7). This study showed the prevalence of infection and incidence of tuberculosis among family contacts of patients with newly diagnosed tuberculosis to be very high. A small number of families with microepidemics accounted for most new cases of tuberculosis, which were also more infectious. The extremely high risk of transmission in these families, together with the proven efficacy of chemoprophylaxis, justifies prescription of chemoprophylaxis to all their members, regardless of age.

Original languageEnglish (US)
Pages (from-to)1327-1331
Number of pages5
JournalEuropean Respiratory Journal
Volume10
Issue number6
DOIs
StatePublished - Jun 1997
Externally publishedYes

Fingerprint

Tuberculosis
Chemoprevention
Odds Ratio
Confidence Intervals
Infection
Incidence
Tuberculin
Sputum
Radiography
Prescriptions

Keywords

  • Chemoprophylaxis
  • Contact tracing
  • Epidemiology
  • Microepidemics
  • Tuberculosis
  • Tuberculosis transmission

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Vidal, R., Miravitlles, M., Cayla, J. A., Torrella, M., De Gracia, J., & Morell, F. (1997). Increased risk of tuberculosis transmission in families with microepidemics. European Respiratory Journal, 10(6), 1327-1331. https://doi.org/10.1183/09031936.97.10061327

Increased risk of tuberculosis transmission in families with microepidemics. / Vidal, R.; Miravitlles, M.; Cayla, J. A.; Torrella, M.; De Gracia, J.; Morell, F.

In: European Respiratory Journal, Vol. 10, No. 6, 06.1997, p. 1327-1331.

Research output: Contribution to journalArticle

Vidal, R, Miravitlles, M, Cayla, JA, Torrella, M, De Gracia, J & Morell, F 1997, 'Increased risk of tuberculosis transmission in families with microepidemics', European Respiratory Journal, vol. 10, no. 6, pp. 1327-1331. https://doi.org/10.1183/09031936.97.10061327
Vidal R, Miravitlles M, Cayla JA, Torrella M, De Gracia J, Morell F. Increased risk of tuberculosis transmission in families with microepidemics. European Respiratory Journal. 1997 Jun;10(6):1327-1331. https://doi.org/10.1183/09031936.97.10061327
Vidal, R. ; Miravitlles, M. ; Cayla, J. A. ; Torrella, M. ; De Gracia, J. ; Morell, F. / Increased risk of tuberculosis transmission in families with microepidemics. In: European Respiratory Journal. 1997 ; Vol. 10, No. 6. pp. 1327-1331.
@article{d0004c61eecc44b0ac26a566d1bbc78e,
title = "Increased risk of tuberculosis transmission in families with microepidemics",
abstract = "In the present study, we analysed: 1) prevalence of TB infection and incidence of disease among family contacts of a cohort of patients with TB; 2) differential characteristics of families with microepidemics and families with ≤1 new case of TB; and 3) efficacy of chemoprophylaxis in this group of contacts. Three thousand and seventy one family contacts of 635 patients with TB were studied. The study consisted of tuberculin skin testing and chest radiography in all cases, and bacteriological studies when active disease was suspected. Contacts were classified as belonging to: families with microepidemics (FME) (those with ≤2 new cases of TB); families with one new case; and families with with no new cases. Chemoprophylaxis was prescribed in contacts following standard recommendations; all were followed up for 12-18 months. Rates of TB infection and disease among families, as well as the incidence of TB disease between those compliant and noncompliant with chemoprophylaxis were compared. Among the 3,071 contacts, 1,264 (41{\%}) were infected and 176 (6{\%}) had TB. Twenty two families with FME (3{\%}) yielded 55 new cases of TB. The prevalence of infection (excluding the TB cases) was 80{\%} in families with FME, 52{\%} in families with one new cases, and 41{\%} in families with no new case (odds ratio (OR) 3.7; 95{\%} confidence interval (95{\%} CI) 2.1- 6.5). Sputum smears were positive in 53{\%} of cases in FME and 24{\%} in non-FME families (OR 3.4; 95{\%} CI 1.7-6.5). Bronchial sample cultures were positive in 84{\%} of patients from FME families but in only 40{\%} of those from non-FME families (OR 7.5; 95{\%} CI 3.6-15.8). Chemoprophylaxis was prescribed in 356 contacts, of whom 296 complied and generated only one new case of TB, whilst there were 13 new cases among the 60 who did not comply (OR 81.6; 95{\%} CI 26.7-248.7). This study showed the prevalence of infection and incidence of tuberculosis among family contacts of patients with newly diagnosed tuberculosis to be very high. A small number of families with microepidemics accounted for most new cases of tuberculosis, which were also more infectious. The extremely high risk of transmission in these families, together with the proven efficacy of chemoprophylaxis, justifies prescription of chemoprophylaxis to all their members, regardless of age.",
keywords = "Chemoprophylaxis, Contact tracing, Epidemiology, Microepidemics, Tuberculosis, Tuberculosis transmission",
author = "R. Vidal and M. Miravitlles and Cayla, {J. A.} and M. Torrella and {De Gracia}, J. and F. Morell",
year = "1997",
month = "6",
doi = "10.1183/09031936.97.10061327",
language = "English (US)",
volume = "10",
pages = "1327--1331",
journal = "European Respiratory Journal, Supplement",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "6",

}

TY - JOUR

T1 - Increased risk of tuberculosis transmission in families with microepidemics

AU - Vidal, R.

AU - Miravitlles, M.

AU - Cayla, J. A.

AU - Torrella, M.

AU - De Gracia, J.

AU - Morell, F.

PY - 1997/6

Y1 - 1997/6

N2 - In the present study, we analysed: 1) prevalence of TB infection and incidence of disease among family contacts of a cohort of patients with TB; 2) differential characteristics of families with microepidemics and families with ≤1 new case of TB; and 3) efficacy of chemoprophylaxis in this group of contacts. Three thousand and seventy one family contacts of 635 patients with TB were studied. The study consisted of tuberculin skin testing and chest radiography in all cases, and bacteriological studies when active disease was suspected. Contacts were classified as belonging to: families with microepidemics (FME) (those with ≤2 new cases of TB); families with one new case; and families with with no new cases. Chemoprophylaxis was prescribed in contacts following standard recommendations; all were followed up for 12-18 months. Rates of TB infection and disease among families, as well as the incidence of TB disease between those compliant and noncompliant with chemoprophylaxis were compared. Among the 3,071 contacts, 1,264 (41%) were infected and 176 (6%) had TB. Twenty two families with FME (3%) yielded 55 new cases of TB. The prevalence of infection (excluding the TB cases) was 80% in families with FME, 52% in families with one new cases, and 41% in families with no new case (odds ratio (OR) 3.7; 95% confidence interval (95% CI) 2.1- 6.5). Sputum smears were positive in 53% of cases in FME and 24% in non-FME families (OR 3.4; 95% CI 1.7-6.5). Bronchial sample cultures were positive in 84% of patients from FME families but in only 40% of those from non-FME families (OR 7.5; 95% CI 3.6-15.8). Chemoprophylaxis was prescribed in 356 contacts, of whom 296 complied and generated only one new case of TB, whilst there were 13 new cases among the 60 who did not comply (OR 81.6; 95% CI 26.7-248.7). This study showed the prevalence of infection and incidence of tuberculosis among family contacts of patients with newly diagnosed tuberculosis to be very high. A small number of families with microepidemics accounted for most new cases of tuberculosis, which were also more infectious. The extremely high risk of transmission in these families, together with the proven efficacy of chemoprophylaxis, justifies prescription of chemoprophylaxis to all their members, regardless of age.

AB - In the present study, we analysed: 1) prevalence of TB infection and incidence of disease among family contacts of a cohort of patients with TB; 2) differential characteristics of families with microepidemics and families with ≤1 new case of TB; and 3) efficacy of chemoprophylaxis in this group of contacts. Three thousand and seventy one family contacts of 635 patients with TB were studied. The study consisted of tuberculin skin testing and chest radiography in all cases, and bacteriological studies when active disease was suspected. Contacts were classified as belonging to: families with microepidemics (FME) (those with ≤2 new cases of TB); families with one new case; and families with with no new cases. Chemoprophylaxis was prescribed in contacts following standard recommendations; all were followed up for 12-18 months. Rates of TB infection and disease among families, as well as the incidence of TB disease between those compliant and noncompliant with chemoprophylaxis were compared. Among the 3,071 contacts, 1,264 (41%) were infected and 176 (6%) had TB. Twenty two families with FME (3%) yielded 55 new cases of TB. The prevalence of infection (excluding the TB cases) was 80% in families with FME, 52% in families with one new cases, and 41% in families with no new case (odds ratio (OR) 3.7; 95% confidence interval (95% CI) 2.1- 6.5). Sputum smears were positive in 53% of cases in FME and 24% in non-FME families (OR 3.4; 95% CI 1.7-6.5). Bronchial sample cultures were positive in 84% of patients from FME families but in only 40% of those from non-FME families (OR 7.5; 95% CI 3.6-15.8). Chemoprophylaxis was prescribed in 356 contacts, of whom 296 complied and generated only one new case of TB, whilst there were 13 new cases among the 60 who did not comply (OR 81.6; 95% CI 26.7-248.7). This study showed the prevalence of infection and incidence of tuberculosis among family contacts of patients with newly diagnosed tuberculosis to be very high. A small number of families with microepidemics accounted for most new cases of tuberculosis, which were also more infectious. The extremely high risk of transmission in these families, together with the proven efficacy of chemoprophylaxis, justifies prescription of chemoprophylaxis to all their members, regardless of age.

KW - Chemoprophylaxis

KW - Contact tracing

KW - Epidemiology

KW - Microepidemics

KW - Tuberculosis

KW - Tuberculosis transmission

UR - http://www.scopus.com/inward/record.url?scp=0031000357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031000357&partnerID=8YFLogxK

U2 - 10.1183/09031936.97.10061327

DO - 10.1183/09031936.97.10061327

M3 - Article

C2 - 9192937

AN - SCOPUS:0031000357

VL - 10

SP - 1327

EP - 1331

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

SN - 0903-1936

IS - 6

ER -